IDRI Receives Grant to Develop a Novel Vaccine to Combat Pandemic Flu

Article

The Infectious Disease Research Institute (IDRI) today announced it has received a multi-million dollar grant from the Defense Advanced Research Projects Agency (DARPA), and the Army Research Office (ARO), both parts of United States Department of Defense. This new funding will support IDRI's development of a single-dose influenza vaccine to be widely administered in case of a pandemic flu outbreak.

The proposal combines cutting-edge vaccine adjuvant technology from IDRI and a microneedle delivery device. Intradermal vaccine delivery has proven benefits over conventional administration methods and may enhance protection as well as allowing for a reduction in the amount of antigen needed. A similar beneficial effect has been observed with some of IDRI's adjuvants.

Dr. Darrick Carter, director of formulations at IDRI and principal investigator, says, "We are in a unique position to bring the vaccine adjuvant and the delivery technologies together to elicit better and more rapid stimulation of the body's defenses." This grant will support IDRI's proof-of-concept preclinical and Phase 1 clinical work, combining technologies to make a vaccine capable of being effective after only a single shot.

The device-adjuvant platform resulting from this program can be applied to intradermal delivery of a variety of vaccine products, targeting many of the world's most challenging diseases.

Related Videos
Andrea Flinchum, 2024 president of the Certification Board of Infection Control and Epidemiology, Inc (CBIC) explains the AL-CIP Certification at APIC24
Association for Professionals in Infection Control and Epidemiology  (Image credit: APIC)
Lila Price, CRCST, CER, CHL, the interim manager for HealthTrust Workforce Solutions; and Dannie O. Smith III, BSc, CSPDT, CRCST, CHL, CIS, CER, founder of Surgicaltrey, LLC, and a central processing educator for Valley Health System
Jill Holdsworth, MS, CIC, FAPIC, CRCST, NREMT, CHL
Jill Holdsworth, MS, CIC, FAPIC, CRCSR, NREMT, CHL, and Katie Belski, BSHCA, CRCST, CHL, CIS
Baby visiting a pediatric facility  (Adobe Stock 448959249 by Rawpixel.com)
Antimicrobial Resistance (Adobe Stock unknown)
Anne Meneghetti, MD, speaking with Infection Control Today
Patient Safety: Infection Control Today's Trending Topic for March
Related Content